Skip to search formSkip to main contentSkip to account menu

MK-7965

Known as: CDK inhibitor SCH 727965 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
KRAS is activated by mutation in the vast majority of cases of pancreatic cancer; unfortunately, therapeutic attempts to inhibit… 
2013
2013
Objectives: Dinaciclib (MK-7965, formerly SCH 727965), a novel, small-molecule inhibitor of cyclindependent kinases, has been… 
Highly Cited
2012
Highly Cited
2012
After more than a decade of clinical development for cancer and numerous failures, Phase III trials of cyclin-dependent kinase…